nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2026, 05, v.46 421-428
木犀草素功能性脂质体制备处方工艺优化及其对Hep3B细胞的影响
基金项目(Foundation): 江西省国际科技合作项目(20232BBH80011); 赣州市科技计划项目(2024RC05)
邮箱(Email): yanghl@gmu.edu.cn;
DOI:
投稿时间: 2026-01-08
投稿日期(年): 2026
修回时间: 2026-05-18
终审时间: 2026-03-25
终审日期(年): 2026
审稿周期(年): 1
发布时间: 2026-05-22
出版时间: 2026-05-22
网络发布时间: 2026-05-22
移动端阅读
摘要:

目的:优化转铁蛋白修饰的木犀草素(Luteolin,LUT)功能性脂质体的制备工艺,并考察其对Hep3B细胞的影响。方法:采用薄膜分散法制备转铁蛋白修饰的木犀草素脂质体(Transferrin-modified luteolin-loaded liposomes,TF-LUT@LIP),以包封率为指标,通过单因素考察和响应面优化法优选最佳制备工艺,并通过CCK-8法和细胞摄取试验考察其对Hep3B细胞活性及摄取情况的影响。结果:最佳处方制备工艺条件为:胆脂比为1∶6.906,药脂比为1∶21.267,超声破碎功率为38%(总功率为650 W),水化温度为50℃,响应面法优化后的木犀草素脂质体平均包封率为96.94%;且当靶向分子投入量为3%时,所制备的TF-LUT@LIP包封率达(95.31±0.03)%,平均粒径为(184.53±0.61) nm,电位为(-23.800±0.500) mV,形态圆整,稳定性良好;TF-LUT@LIP对Hep3B细胞的抑制作用强于游离LUT,并呈浓度依赖性,且与非靶向脂质体相比,TF-LUT@LIP的摄取行为更明显。结论:按照最优制备工艺制备的TF-LUT@LIP包封率高、形态规整、粒径均匀,且对Hep3B细胞的抑制作用明显,细胞摄取行为良好。

Abstract:

Objective : To optimize the preparation process of transferrin modified functional liposomes of magnolol and to investigate their effects on Hep3B cells. Methods : Transferrin-modified luteolin-loaded liposomes(TF-LUT@LIP) was synthesized using the thin-film dispersion method. The encapsulation efficiency served as the evaluation criterion. Optimal preparation conditions were determined through single-factor experiments and response surface optimization. The effects on Hep3B cell viability and uptake were assessed via CCK-8 assays and cellular uptake experiments. Results : The optimal formulation preparation conditions are as follows: bile-to-lipid ratio of 1∶6. 906, drug-to-lipid ratio of 1∶21. 267, ultrasonication power of 38%(total power 650 W), and hydration temperature of 50 ℃. The response surface methodologyoptimized luteolin liposomes achieved an average encapsulation efficiency of 96. 94%. When the target molecule loading was 3%, the prepared TF-LUT@LIP exhibited(95. 31±0. 03)%, an average particle size of(184. 53±0. 61) nm, a zeta potential of (-23. 800±0. 500) mV, and excellent stability. TF-LUT@LIP exhibited stronger concentration-dependent inhibitory effects on Hep3B cells than free luteolin(LUT). Compared to non-targeted liposomes, TF-LUT@LIP demonstrated significantly enhanced uptake behavior. Conclusion : TF-LUT@LIP prepared via the optimal synthesis process exhibits high encapsulation efficiency, uniform morphology, and consistent particle size distribution. It demonstrates significant inhibitory effects on Hep3B cells and exhibits favorable cellular uptake behavior.

参考文献

[1]Punia Bangar S,Kajla P,Chaudhary V,et al. Luteolin:a flavone with myriads of bioactivities and food applications[J]. Food Biosci,2023,52:102366.

[2]姜亚玲,李文渊,冯爽,等.木犀草素的结构修饰及其生物活性研究进展[J].中草药,2023,54(20):6889-6902.

[3]Yao C,Dai S,Wang C,et al. Luteolin as a potential hepatoprotective drug:Molecular mechanisms and treatment strategies[J]. Biomedecine Pharmacother,2023,167:115464.

[4]Taheri Y,Sharifi-Rad J,Antika G,et al. Paving luteolin therapeutic potentialities and agro-food-pharma applications:emphasis on in vivo pharmacological effects and bioavailability traits[J]. Oxid Med Cell Longev,2021,2021:1987588.

[5]Muruganathan N,Dhanapal A R,Baskar V,et al. Recent updates on source,biosynthesis,and therapeutic potential of natural flavonoid luteolin:a review[J]. Metabolites,2022,12(11):1145.

[6]高梦璇,蒋秀梅,叶金翠,等.木犀草素经皮给药微针系统的构建及关节炎药效评价[J].中国药学杂志,2025,60(14):1493-1501.

[7]刘淼,高悦,李康帆,等.聚乙二醇修饰木犀草素脂质体的制备及其理化性质[J].现代食品科技,2021,37(10):118-125.

[8]黄子婷,王梦颜,常金花,等.木犀草素固体分散体的体外溶出度和体内药动学研究[J].中国药房,2024,35(10):1215-1219.

[9]常炳程,何蔚,夏志鸿.木犀草素/阿霉素双载药纳米粒治疗三阴乳腺癌的体外研究[J].药品评价,2021,18(20):1226-1229.

[10]Large D E,Abdelmessih R G,Fink E A,et al. Liposome composition in drug delivery design, synthesis, characterization,and clinical application[J]. Adv Drug Deliv Rev,2021,176:113851.

[11]Dymek M,Sikora E. Liposomes as biocompatible and smart delivery systems-the current state[J]. Adv Colloid Interface Sci,2022,309:102757.

[12]杜桑,崔韶晖,陈星妍,等.脂质体递药系统的靶向修饰[J].生物化学与生物物理进展,2023,50(6):1272-1285.

[13]Nel J, Elkhoury K, VelotÉ,et al. Functionalized liposomes for targeted breast cancer drug delivery[J]. Bioact Mater,2023,24:401-437.

[14]Zhao X,Yang Y,Su X,et al. Transferrin-modified triptolide liposome targeting enhances anti-hepatocellular carcinoma effects[J]. Biomedicines,2023,11(10):2869.

[15]Li J,Cheng X,Chen Y,et al. Vitamin E TPGS modified liposomes enhance cellular uptake and targeted delivery of luteolin:an in vivo/in vitro evaluation[J]. Int J Pharm,2016,512(1):262-272.

[16]郭丽丽,高欣缘,谷兆怡,等.黄芪茎叶总黄酮脂质体的制备及其理化性质分析[J].食品科技,2024,49(10):284-292.

[17]Weng W, Wang Q, Wei C, et al. Preparation, characterization,pharmacokinetics and anti-hyperuricemia activity studies of myricitrin-loaded proliposomes[J]. Int J Pharm,2019,572:118735.

[18]陆倩,国小利,杨雅欣,等.木犀草素脂质体冻干工艺优化及其对LX-2细胞的影响[J].生物技术,2022,32(5):598-604.

[19]Ansari M H. Preclinical drug development process:formulation and development aspects[J]. Int J Med Pharm Sci,2023,13(3):1-10.

[20]金彤彤,陆雯沁,张傅瑜淇,等.脂质体稳定性影响因素的研究[J].光谱学与光谱分析,2023,43(S1):287-288.

[21]Silva R, Ferreira H, Little C, et al. Effect of ultrasound parameters for unilamellar liposome preparation[J].Ultrason Sonoch,2010,17(1):628-632.

基本信息:

中图分类号:R943;R96

引用信息:

[1]娄思思,李风叶,杨海龙.木犀草素功能性脂质体制备处方工艺优化及其对Hep3B细胞的影响[J].赣南医科大学学报,2026,46(05):421-428.

基金信息:

江西省国际科技合作项目(20232BBH80011); 赣州市科技计划项目(2024RC05)

投稿时间:

2026-01-08

投稿日期(年):

2026

修回时间:

2026-05-18

终审时间:

2026-03-25

终审日期(年):

2026

审稿周期(年):

1

发布时间:

2026-05-22

出版时间:

2026-05-22

网络发布时间:

2026-05-22

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文